The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Polestar Automotive Holding UK PLC — Neutral
PSNY Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Polestar Automotive Holding UK PLC ("Polestar" or "the Company") (NASDAQ:PSNY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 14, 2022 and January 16, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc. — Neutral
APLT Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
Integral Ad Science Holding Corp. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
IAS Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integral Ad Science Holding Corp. ("IAS" or "the Company") (NASDAQ:IAS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 2, 2023, and February 27, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.
Air Products to Showcase Industrial Decarbonization Solutions at POWERGEN International in Dallas, Texas — Neutral
APD PRNewsWire — February 10, 2025Air Products' Industry Experts will Present the Details of Recent Hydrogen Boiler Trials, as well as Information on Hydrogen's Role in Enhancing Microgrid Resilience LEHIGH VALLEY, Pa. , Feb. 10, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will highlight how its industrial gases, such as hydrogen, can help the power industry generate a cleaner future and reach its decarbonization goals at POWERGEN International, from February 11-13, at the Kay Bailey Hutchison Convention Center in Dallas, Texas.
Instacart's Smart Trolleys are Now Available at Coles Supermarkets in Australia — Neutral
CART PRNewsWire — February 10, 2025Coles Supermarkets is the first retailer in the Asia Pacific region to deploy Caper Carts, Instacart's AI-powered smart trolleys SAN FRANCISCO and MELBOURNE, Australia , Feb. 10, 2025 /PRNewswire/ -- Instacart (NASDAQ: CART), the leading grocery technology company in North America, and Coles Supermarkets (ASX: COL), one of Australia's leading retailers, today announced the rollout of Caper Carts, Instacart's AI-powered smart trolleys, at its Richmond Traders location in Melbourne. Customers can now shop smarter, bag as they shop, and pay directly on the Coles Smart Trolley for a seamless in-store shopping experience.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc. — Neutral
REGN Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 10, 2025.
Cardlytics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
CDLX Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 14, 2024 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.
The Schall Law Firm Invites Investors With Losses In Celanese Corporation To Join A Securities Fraud Investigation — Neutral
CE Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Red Cat Holdings, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
RCAT Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Red Cat Holdings, Inc. ("Red Cat" or "the Company") (NASDAQ:RCAT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
CARGO Therapeutics, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
CRGX Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CARGO Therapeutics, Inc. ("CARGO" or "the Company") (NASDAQ:CRGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Long-Term Monolithic Power Systems, Inc. (Nasdaq: MPWR) Shareholders are Encouraged to Contact Grabar Law Office — Neutral
MPWR GlobeNewsWire — February 10, 2025PHILADELPHIA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of Monolithic Power Systems, Inc. (NASDAQ: MPWR) shareholders. The investigation concerns whether certain officers and directors of Monolithic have breached their fiduciary duties owed to the company.
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term — Positive
DGX Zacks Investment Research — February 10, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EnerSys (ENS) is a Top-Ranked Momentum Stock: Should You Buy? — Positive
ENS Zacks Investment Research — February 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Ensign Group (ENSG) is a Top Momentum Stock for the Long-Term — Positive
ENSG Zacks Investment Research — February 10, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Clearway Energy (CWEN) is a Top Momentum Stock for the Long-Term — Positive
CWEN Zacks Investment Research — February 10, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Royal Caribbean (RCL) is a Strong Momentum Stock — Positive
RCL Zacks Investment Research — February 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Logitech (LOGI) is a Strong Momentum Stock — Positive
LOGI Zacks Investment Research — February 10, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
What to Expect From Service Corporation in Q4 Earnings Release? — Positive
SCI Zacks Investment Research — February 10, 2025SCI's Q4 results are likely to reflect gains from a resilient business model and favorable demographics.
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 333.01%: Read This Before Placing a Bet — Positive
RGNX Zacks Investment Research — February 10, 2025The consensus price target hints at a 333% upside potential for Regenxbio (RGNX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Hercules Capital: Hybrid Strategy Crafts A BDC Winner — Positive
HTGC Seeking Alpha — February 10, 2025Hercules Capital brings a conservative yet flexible BDC strategy and a focus on innovative companies as dealmaking targets. The leadership team boasts extensive and varied financial experience. Its track record should create confidence for investors. Hercules' business strategy is based on a selective approach to dealmaking, consistent liquidity maintenance and flexible loan structuring fit to target company situations.